Aurinia Pharmaceuticals, Inc. (AUPH)
15.74
-0.09
(-0.57%)
USD |
NASDAQ |
Oct 05, 16:00
15.74
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap : 2.092B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.104B |
| October 01, 2026 | 2.120B |
| September 30, 2026 | 2.152B |
| September 29, 2026 | 2.182B |
| September 28, 2026 | 2.196B |
| September 25, 2026 | 2.185B |
| September 24, 2026 | 2.206B |
| September 23, 2026 | 2.180B |
| September 22, 2026 | 2.216B |
| September 21, 2026 | 2.208B |
| September 18, 2026 | 2.246B |
| September 17, 2026 | 2.254B |
| September 16, 2026 | 2.254B |
| September 15, 2026 | 2.144B |
| September 14, 2026 | 2.181B |
| September 11, 2026 | 2.140B |
| September 10, 2026 | 2.141B |
| September 09, 2026 | 2.160B |
| September 08, 2026 | 2.136B |
| September 04, 2026 | 2.137B |
| September 03, 2026 | 2.142B |
| September 02, 2026 | 2.165B |
| September 01, 2026 | 2.133B |
| August 31, 2026 | 2.141B |
| August 28, 2026 | 2.165B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.190B |
| August 26, 2026 | 2.198B |
| August 25, 2026 | 2.226B |
| August 24, 2026 | 2.202B |
| August 21, 2026 | 2.213B |
| August 20, 2026 | 2.295B |
| August 19, 2026 | 2.149B |
| August 18, 2026 | 2.033B |
| August 17, 2026 | 2.032B |
| August 14, 2026 | 2.056B |
| August 13, 2026 | 2.018B |
| August 12, 2026 | 2.053B |
| August 11, 2026 | 2.043B |
| August 10, 2026 | 2.053B |
| August 07, 2026 | 2.107B |
| August 06, 2026 | 2.144B |
| August 05, 2026 | 2.019B |
| August 04, 2026 | 1.984B |
| August 03, 2026 | 1.905B |
| July 31, 2026 | 1.946B |
| July 30, 2026 | 1.962B |
| July 29, 2026 | 1.985B |
| July 28, 2026 | 1.956B |
| July 27, 2026 | 1.990B |
| July 24, 2026 | 2.007B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| enGene Therapeutics, Inc. | 124.98M |
| Medicus Pharma Ltd. | 10.12M |
| Xenon Pharmaceuticals, Inc. | 3.636B |
| Psyence Biomedical Ltd. | 11.47M |
| Agenus, Inc. | 372.03M |
Market Cap Related Metrics
| PE Ratio | 6.881 |
| PS Ratio | 6.889 |
| PEG Ratio | 0.0158 |
| Price to Book Value | 3.402 |
| Price to Free Cash Flow | 12.32 |
| Price | 15.74 |
| Earnings Yield | 14.53% |
| PEGY Ratio | 0.0158 |
| Operating PE Ratio | 15.26 |
| Normalized PE Ratio | 6.881 |